• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌阵挛性小脑协调障碍 3 型(SCA3)小鼠模型中肌醇 1,4,5-三磷酸受体 2(IPR2)的遗传缺失未能改变疾病进展。

Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IPR2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3.

机构信息

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.

ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga/4805-017 Guimarães, Portugal.

出版信息

Int J Mol Sci. 2023 Jun 25;24(13):10606. doi: 10.3390/ijms241310606.

DOI:10.3390/ijms241310606
PMID:37445783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10341520/
Abstract

Spinocerebellar ataxia type 3 (SCA3) is a rare neurodegenerative disease caused by an abnormal polyglutamine expansion within the ataxin-3 protein (ATXN3). This leads to neurodegeneration of specific brain and spinal cord regions, resulting in a progressive loss of motor function. Despite neuronal death, non-neuronal cells, including astrocytes, are also involved in SCA3 pathogenesis. Astrogliosis is a common pathological feature in SCA3 patients and animal models of the disease. However, the contribution of astrocytes to SCA3 is not clearly defined. Inositol 1,4,5-trisphosphate receptor type 2 (IPR2) is the predominant IPR in mediating astrocyte somatic calcium signals, and genetically ablation of IPR2 has been widely used to study astrocyte function. Here, we aimed to investigate the relevance of IPR2 in the onset and progression of SCA3. For this, we tested whether IPR2 depletion and the consecutive suppression of global astrocytic calcium signalling would lead to marked changes in the behavioral phenotype of a SCA3 mouse model, the CMVMJD135 transgenic line. This was achieved by crossing IPR2 null mice with the CMVMJD135 mouse model and performing a longitudinal behavioral characterization of these mice using well-established motor-related function tests. Our results demonstrate that IPR2 deletion in astrocytes does not modify SCA3 progression.

摘要

脊髓小脑共济失调 3 型(SCA3)是一种罕见的神经退行性疾病,由ataxin-3 蛋白(ATXN3)内异常的多聚谷氨酰胺扩展引起。这导致特定脑和脊髓区域的神经变性,导致运动功能逐渐丧失。尽管神经元死亡,但包括星形胶质细胞在内的非神经元细胞也参与了 SCA3 的发病机制。星形胶质细胞增生是 SCA3 患者和疾病动物模型的常见病理特征。然而,星形胶质细胞对 SCA3 的贡献尚不清楚。三磷酸肌醇受体 2(IPR2)是介导星形胶质体细胞钙信号的主要 IPR,IPR2 的基因缺失已广泛用于研究星形胶质细胞功能。在这里,我们旨在研究 IPR2 在 SCA3 发病和进展中的相关性。为此,我们测试了 IPR2 耗竭和随后抑制全局星形胶质细胞钙信号是否会导致 SCA3 小鼠模型,即 CMVMJD135 转基因系的行为表型发生明显变化。这是通过将 IPR2 缺失小鼠与 CMVMJD135 小鼠模型杂交,并使用成熟的与运动相关的功能测试对这些小鼠进行纵向行为特征分析来实现的。我们的结果表明,星形胶质细胞中 IPR2 的缺失不会改变 SCA3 的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/3389d93972bf/ijms-24-10606-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/f75cb1bc3fa1/ijms-24-10606-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/8fe470b0cdd3/ijms-24-10606-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/a31feca66c4a/ijms-24-10606-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/3389d93972bf/ijms-24-10606-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/f75cb1bc3fa1/ijms-24-10606-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/8fe470b0cdd3/ijms-24-10606-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/a31feca66c4a/ijms-24-10606-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/10341520/3389d93972bf/ijms-24-10606-g004a.jpg

相似文献

1
Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IPR2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3.肌阵挛性小脑协调障碍 3 型(SCA3)小鼠模型中肌醇 1,4,5-三磷酸受体 2(IPR2)的遗传缺失未能改变疾病进展。
Int J Mol Sci. 2023 Jun 25;24(13):10606. doi: 10.3390/ijms241310606.
2
Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis.小脑萎缩 3 型疾病发病机制中的早期特征是少突胶质细胞成熟受损。
J Neurosci. 2022 Feb 23;42(8):1604-1617. doi: 10.1523/JNEUROSCI.1954-20.2021. Epub 2022 Jan 18.
3
Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.3型脊髓小脑共济失调小鼠模型的比较确定了少突胶质细胞早期功能获得性、细胞自主转录变化。
Hum Mol Genet. 2017 Sep 1;26(17):3362-3374. doi: 10.1093/hmg/ddx224.
4
Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.转录谱分析和生物标志物鉴定揭示扩展型共济失调-3 在脊髓小脑共济失调 3 型小鼠模型中的组织特异性效应。
Mol Neurodegener. 2018 Jun 22;13(1):31. doi: 10.1186/s13024-018-0261-9.
5
Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons.星形胶质细胞中 NF-κB 的抑制足以延缓神经元蛋白毒性诱导的神经退行性变。
J Neuroinflammation. 2018 Sep 11;15(1):261. doi: 10.1186/s12974-018-1278-2.
6
Disruption of IP₃R2-mediated Ca²⁺ signaling pathway in astrocytes ameliorates neuronal death and brain damage while reducing behavioral deficits after focal ischemic stroke.星形胶质细胞中IP₃R2介导的Ca²⁺信号通路的破坏可改善神经元死亡和脑损伤,同时减少局灶性缺血性中风后的行为缺陷。
Cell Calcium. 2015 Dec;58(6):565-76. doi: 10.1016/j.ceca.2015.09.004. Epub 2015 Sep 25.
7
In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.利鲁唑作为3型脊髓小脑共济失调潜在治疗药物的体内评估。
J Neurochem. 2016 Jul;138(1):150-62. doi: 10.1111/jnc.13606.
8
A Novel SCA3 Knock-in Mouse Model Mimics the Human SCA3 Disease Phenotype Including Neuropathological, Behavioral, and Transcriptional Abnormalities Especially in Oligodendrocytes.一种新型 SCA3 基因敲入小鼠模型模拟人类 SCA3 疾病表型,包括神经病理学、行为和转录异常,特别是在少突胶质细胞中。
Mol Neurobiol. 2022 Jan;59(1):495-522. doi: 10.1007/s12035-021-02610-8. Epub 2021 Oct 30.
9
Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.寡核苷酸疗法减轻脊髓小脑共济失调 3 型小鼠的疾病。
Ann Neurol. 2018 Jul;84(1):64-77. doi: 10.1002/ana.25264. Epub 2018 Aug 6.
10
The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits.应激颗粒蛋白 G3BP1 可减轻脊髓小脑共济失调相关缺陷。
Brain. 2023 Jun 1;146(6):2346-2363. doi: 10.1093/brain/awac473.

引用本文的文献

1
Treatment of neurological pathology and inflammation in Machado-Joseph disease through in vivo self-assembled siRNA.通过体内自组装小干扰RNA治疗马查多-约瑟夫病中的神经病理学和炎症
Brain. 2025 Mar 6;148(3):817-832. doi: 10.1093/brain/awae304.

本文引用的文献

1
Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado-Joseph Disease.小胶质细胞耗竭对 Machado-Joseph 病小鼠模型疾病进展无影响。
Cells. 2022 Jun 25;11(13):2022. doi: 10.3390/cells11132022.
2
Profiling Microglia in a Mouse Model of Machado-Joseph Disease.在马查多-约瑟夫病小鼠模型中分析小胶质细胞
Biomedicines. 2022 Jan 23;10(2):237. doi: 10.3390/biomedicines10020237.
3
Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3.基于间充质干细胞的疗法在3型脊髓小脑共济失调中的临床前评估
Biomedicines. 2021 Nov 24;9(12):1754. doi: 10.3390/biomedicines9121754.
4
Clinical, Imaging, and Laboratory Markers of Premanifest Spinocerebellar Ataxia 1, 2, 3, and 6: A Systematic Review.临床前期脊髓小脑共济失调1型、2型、3型和6型的临床、影像学及实验室指标:一项系统评价
J Clin Neurol. 2021 Apr;17(2):187-199. doi: 10.3988/jcn.2021.17.2.187.
5
IP R2 null mice display a normal acquisition of somatic and neurological development milestones.IP R2 基因敲除小鼠在躯体和神经发育里程碑方面的获得表现正常。
Eur J Neurosci. 2021 Sep;54(5):5673-5686. doi: 10.1111/ejn.14724. Epub 2020 Apr 6.
6
Astrocyte-Neuron Networks: A Multilane Highway of Signaling for Homeostatic Brain Function.星形胶质细胞-神经元网络:维持大脑稳态功能的多车道信号传导通路
Front Synaptic Neurosci. 2018 Nov 27;10:45. doi: 10.3389/fnsyn.2018.00045. eCollection 2018.
7
The Role of Astrocytic Calcium Signaling in the Aged Prefrontal Cortex.星形胶质细胞钙信号在老年前额叶皮质中的作用
Front Cell Neurosci. 2018 Nov 5;12:379. doi: 10.3389/fncel.2018.00379. eCollection 2018.
8
Inositol 1,4,5-trisphosphate receptor type 2-independent Ca release from the endoplasmic reticulum in astrocytes.内质网中肌醇 1,4,5-三磷酸受体 2 非依赖性 Ca2+释放与星形胶质细胞。
Glia. 2019 Jan;67(1):113-124. doi: 10.1002/glia.23531. Epub 2018 Oct 11.
9
Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons.星形胶质细胞中 NF-κB 的抑制足以延缓神经元蛋白毒性诱导的神经退行性变。
J Neuroinflammation. 2018 Sep 11;15(1):261. doi: 10.1186/s12974-018-1278-2.
10
Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease.支持在 Machado-Joseph 病中早期启动西酞普兰治疗的临床前证据。
Mol Neurobiol. 2019 May;56(5):3626-3637. doi: 10.1007/s12035-018-1332-1. Epub 2018 Sep 1.